| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
|
| | 1004316-84-0 Basic information |
| Product Name: | 1004316-84-0 | | Synonyms: | (S)-4-((tert-Butoxycarbonyl)amino)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)butanoic acid;4-[(2-Methylpropan-2-YL)oxycarbonylamino]-2-[[methyl-[(2-propan-2-YL-1,3-thiazol-4-YL)methyl]carbamoyl]amino]butanoic acid;Butanoic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-, (2S)- | | CAS: | 1004316-84-0 | | MF: | C18H30N4O5S | | MW: | 414.52 | | EINECS: | | | Product Categories: | | | Mol File: | 1004316-84-0.mol |  |
| | 1004316-84-0 Chemical Properties |
| Boiling point | 654.5±55.0 °C(Predicted) | | density | 1.216±0.06 g/cm3(Predicted) | | pka | 4.28±0.10(Predicted) |
| | 1004316-84-0 Usage And Synthesis |
| Uses | (2S)-4-(tert-Butoxycarbonylamino)-2-[[[2-(1-methylethyl)thiazol-4-yl]methyl(methyl)carbamoyl]amino]butanoic Acid may be useful in the study of compounds as modulators of pharmacokinetic properties of therapeutic agents useful in combination therapy of diseases. |
| | 1004316-84-0 Preparation Products And Raw materials |
|